Works matching IS 14611457 AND DT 2017 AND VI 20 AND IP 8

Results: 9

Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder.
Published in:
International Journal of Neuropsychopharmacology, 2017, v. 20, n. 8, p. 613, doi. 10.1093/ijnp/pyx033
By:
- Connor, Kathryn M.;
- Ceesay, Paulette;
- Hutzelmann, Jill;
- Snavely, Duane;
- Krystal, Andrew D.;
- Trivedi, Madhukar H.;
- Thase, Michael;
- Lines, Christopher;
- Herring, W. Joseph;
- Michelson, David
Publication type:
Article
CORRIGENDUM.
Published in:
2017
Publication type:
Correction Notice
Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies.
Published in:
International Journal of Neuropsychopharmacology, 2017, v. 20, n. 8, p. 670, doi. 10.1093/ijnp/pyx032
By:
- Solé, Brisa;
- Jiménez, Esther;
- Torrent, Carla;
- Reinares, Maria;
- del Mar Bonnin, Caterina;
- Torres, Imma;
- Varo, Cristina;
- Grande, Iria;
- Valls, Elia;
- Salagre, Estela;
- Sanchez-Moreno, Jose;
- Martinez-Aran, Anabel;
- Carvalho, André F.;
- Vieta, Eduard
Publication type:
Article
Mechanisms of Kappa Opioid Receptor Potentiation of Dopamine D2 Receptor Function in Quinpirole-Induced Locomotor Sensitization in Rats.
Published in:
International Journal of Neuropsychopharmacology, 2017, v. 20, n. 8, p. 660, doi. 10.1093/ijnp/pyx042
By:
- Escobar, Angélica P.;
- González, Marcela P.;
- Meza, Rodrigo C.;
- Noches, Verónica;
- Henny, Pablo;
- Gysling, Katia;
- España, Rodrigo A.;
- Fuentealba, José A.;
- Andrés, María E.
Publication type:
Article
Facilitation of Contextual Fear Extinction by Orexin-1 Receptor Antagonism Is Associated with the Activation of Specific Amygdala Cell Subpopulations.
Published in:
International Journal of Neuropsychopharmacology, 2017, v. 20, n. 8, p. 654, doi. 10.1093/ijnp/pyx029
By:
- Flores, África;
- Herry, Cyril;
- Maldonado, Rafael;
- Berrendero, Fernando
Publication type:
Article
Preclinical Evidence That 5-HT<sub>1B</sub> Receptor Agonists Show Promise as Medications for Psychostimulant Use Disorders.
Published in:
International Journal of Neuropsychopharmacology, 2017, v. 20, n. 8, p. 644, doi. 10.1093/ijnp/pyx025
By:
- Garcia, Raul;
- Cotter, Austin R.;
- Leslie, Kenneth;
- Olive, M. Foster;
- Neisewander, Janet L.
Publication type:
Article
Acute and Chronic Noradrenergic Effects on Cortical Excitability in Healthy Humans.
Published in:
International Journal of Neuropsychopharmacology, 2017, v. 20, n. 8, p. 634, doi. 10.1093/ijnp/pyx026
By:
- Hsiao-I Kuo;
- Paulus, Walter;
- Batsikadze, Giorgi;
- Jamil, Asif;
- Min-Fang Kuo;
- Nitsche, Michael A.
Publication type:
Article
Cognitive Training Using a Novel Memory Game on an iPad in Patients with Amnestic Mild Cognitive Impairment (aMCI).
Published in:
International Journal of Neuropsychopharmacology, 2017, v. 20, n. 8, p. 624, doi. 10.1093/ijnp/pyx040
By:
- Savulich, George;
- Piercy, Thomas;
- Fox, Chris;
- Suckling, John;
- Rowe, James B.;
- O'Brien, John T.;
- Sahakian, Barbara J.
Publication type:
Article
Investigation of miR-1202, miR-135a, and miR-16 in Major Depressive Disorder and Antidepressant Response.
Published in:
International Journal of Neuropsychopharmacology, 2017, v. 20, n. 8, p. 619, doi. 10.1093/ijnp/pyx034
By:
- Fiori, Laura M.;
- Lopez, Juan Pablo;
- Richard-Devantoy, Stéphane;
- Berlim, Marcelo;
- Chachamovich, Eduardo;
- Jollant, Fabrice;
- Foster, Jane;
- Rotzinger, Susan;
- Kennedy, Sidney H.;
- Turecki, Gustavo
Publication type:
Article